Iluka Resources Ltd:企業の戦略・SWOT・財務情報

◆英語タイトル:Iluka Resources Ltd - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C6661
◆発行会社(調査会社):MarketLine
◆発行日:2018年10月
◆ページ数:44
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストラリア
◆産業分野:金属・鉱業
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Iluka Resources Ltd – Strategy, SWOT and Corporate Finance Report
Summary

Iluka Resources Ltd – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Iluka Resource Limited (Iluka) is a mineral sands company in Australia. It involves in exploration, project development, operation and marketing of mineral sands products. The company’s key assets and operations are situated in Australia, with a mining and processing operation in Virginia, the US. Iluka is the largest producer of zircon in the world. It also produces titanium dioxide minerals such as rutile, ilmenite and synthetic rutile. The company also has a royalty over iron ore sales revenue from certain tenements of BHP Billiton’s Mining Area C (MAC) province in Western Australia. The company’s products find application in a diverse range of sectors such as consumer, industrial, manufacturing, aircraft and healthcare. Iluka is headquartered in Perth, Western Australia, Australia.

Scope

- Detailed information on Iluka Resources Ltd required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Iluka Resources Ltd in the form of a SWOT analysis
- An in-depth view of the business model of Iluka Resources Ltd including a breakdown and examination of key business segments
- Intelligence on Iluka Resources Ltd’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Iluka Resources Ltd, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Iluka Resources Ltd and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Iluka Resources Ltd as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Iluka Resources Ltd’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Iluka Resources Ltd: Company Overview 9
Iluka Resources Ltd: Overview and Key Facts 9
Iluka Resources Ltd: Overview 9
Iluka Resources Ltd: Key Facts 9
Iluka Resources Ltd: Key Employees 11
Iluka Resources Ltd: Key Employee Biographies 13
Iluka Resources Ltd: Major Products and Services 14
Iluka Resources Ltd: Company History 15
Iluka Resources Ltd: Management Statement 17
Iluka Resources Ltd: Locations and Subsidiaries 19
Iluka Resources Ltd: Key Competitors 21
Iluka Resources Ltd: Company Analysis 22
Iluka Resources Ltd: Business Description 22
Iluka Resources Ltd: SWOT Analysis 25
Iluka Resources Ltd: SWOT Overview 25
Iluka Resources Ltd: Strengths 25
Iluka Resources Ltd: Weaknesses 26
Iluka Resources Ltd: Opportunities 26
Iluka Resources Ltd: Threats 27
Iluka Resources Ltd: Corporate Financial Deals Activity 28
Iluka Resources Ltd: Financial Deals Overview 28
Iluka Resources Ltd: Targets and Partners 30
Iluka Resources Ltd: Top Deals 2014 – 2018YTD* 31
Iluka Resources Ltd: Mergers and Acquisitions 32
Iluka Resources Ltd: Corporate Venturing 33
Iluka Resources Ltd: Partnership 34
Iluka Resources Ltd: Recent Developments 35
Iluka Resources Ltd: News and Events Summary 35
Iluka Resources Ltd: Business Expansion 38
Iluka Resources Ltd: Contracts 38
Iluka Resources Ltd: Corporate Governance 39
Iluka Resources Ltd: Red Flags/DistressSignals 40
Iluka Resources Ltd: Regulatory and Legal Events 40
Iluka Resources Ltd: Strategy and Operations 40
Appendix 42
Contact Us 42
Methodology 42
About MarketLine 43

List of Tables
Table 1: Iluka Resources Ltd: Key Facts
Table 2: Iluka Resources Ltd: Key Employees
Table 3: Iluka Resources Ltd: Company History
Table 4: Iluka Resources Ltd: Locations and Subsidiaries
Table 5: Iluka Resources Ltd: Key Competitors
Table 6: Iluka Resources Ltd: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Iluka Resources Ltd: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 8: Iluka Resources Ltd: M&A Average Deal Size - Value (US$m)
Table 9: Iluka Resources Ltd: Targets and Partners
Table 10: Iluka Resources Ltd: Top Deals 2014 - 2018YTD*
Table 11: Iluka Resources Ltd: M&A Volume and Value Trend (2014 - YTD*2018)
Table 12: Iluka Resources Ltd: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Table 13: Iluka Resources Ltd: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 14: Iluka Resources Ltd: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 15: Iluka Resources Ltd: News and Events Summary
Table 16: Iluka Resources Ltd: Business Expansion
Table 17: Iluka Resources Ltd: Contracts
Table 18: Iluka Resources Ltd: Corporate Governance
Table 19: Iluka Resources Ltd: Red Flags/DistressSignals
Table 20: Iluka Resources Ltd: Regulatory and Legal Events
Table 21: Iluka Resources Ltd: Strategy and Operations

List of Figures
Figure 1: Iluka Resources Ltd: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Iluka Resources Ltd: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 3: Iluka Resources Ltd: M&A Average Deal Size - Value (US$m)
Figure 4: Iluka Resources Ltd: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 5: Iluka Resources Ltd: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Figure 6: Iluka Resources Ltd: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 7: Iluka Resources Ltd: Partnership Trend by Deal Type (2014 - YTD*2018)

★海外企業調査レポート[Iluka Resources Ltd:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Catalyst Paper Corporation:企業の戦略的SWOT分析
    Catalyst Paper Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • China Petroleum & Chemical Corporation (Sinopec):戦略・SWOT・企業財務分析
    China Petroleum & Chemical Corporation (Sinopec) - Strategy, SWOT and Corporate Finance Report Summary China Petroleum & Chemical Corporation (Sinopec) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, …
  • China National Chemical Corp:石油・ガス:M&Aディール及び事業提携情報
    Summary China National Chemical Corp (ChemChina) is a state-owned enterprise that develops and markets chemicals. The company offers chemical materials and specialty chemicals, agrochemicals, oil processing and refining products, basic chemicals, and rubber products. ChemChina also manufactures equi …
  • Nordea Bank AB:企業のM&A・事業提携・投資動向
    Nordea Bank AB - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Nordea Bank AB Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • RaQualia Pharma Inc (4579):製薬・医療:M&Aディール及び事業提携情報
    Summary RaQualia Pharma Inc (RaQualia) is a drug development company that discovers and develops pharmaceutical compounds. The company offers products such as anidulafungin, ziprasidone, dalbavancin, 5-HT2B antagonist, motilin receptor agonist, potassium-competitive acid blockerand 5-HT4 partial ago …
  • JK Paper Ltd.:企業の戦略・SWOT・財務情報
    JK Paper Ltd. - Strategy, SWOT and Corporate Finance Report Summary JK Paper Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Ineos Group AG:石油・ガス:M&Aディール及び事業提携情報
    Summary Ineos Group AG (Ineos), a subsidiary of INEOS Group Holdings SA, is a chemical manufacturing company. It manufactures and sells petrochemicals, specialty chemicals and oil products. The company’s products include ammonia, nitric acid, sea salt, esters, bio fuel, sulphuric acid, amino resin, …
  • Firestone Diamonds plc:企業の戦略・SWOT・財務情報
    Firestone Diamonds plc - Strategy, SWOT and Corporate Finance Report Summary Firestone Diamonds plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Pardus Oil & Gas LLC:石油・ガス:M&Aディール及び事業提携情報
    Summary Pardus Oil & Gas LLC (Pardus Oil & Gas), formerly Energy & Exploration Partners LLC, is an oil and gas exploration and development company that acquires, explores, develops and produces onshore unconventional oil and natural gas assets in East Texas. The company operates oil and liquids-rich …
  • Clinigen Group Plc (CLIN):企業の財務・戦略的SWOT分析
    Summary Clinigen Group Plc (Clinigen Group) operates as a pharmaceutical and services company that provides access to clinical trials, medicines, unlicensed and commercial supply. The company acquires and licenses essential commercial medicines such as foscavir, cardioxane, ethyol, savene and vibati …
  • Vivendi S.A. (VIV):企業の財務・戦略的SWOT分析
    Vivendi S.A. (VIV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Vallourec Sa
    Vallourec Sa - Strategy, SWOT and Corporate Finance Report Summary Vallourec Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Canam Group Inc:企業の戦略的SWOT分析
    Canam Group Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Canadian Solar Inc (CSIQ):電力:M&Aディール及び事業提携情報
    Summary Canadian Solar Inc (Canadian Solar) is a solar power company. It designs, develops, and manufactures solar ingots, wafers, modules, cells, and other solar power products. The company’s products include a range of solar modules for use in residential, commercial and industrial solar power gen …
  • Spinal Elements Inc:医療機器:M&Aディール及び事業提携情報
    Summary Spinal Elements Inc (Spinal Elements), formerly Quantum Orthopedics Inc, a subsidiary of Spinal Elements, is a medical device manufacturing company that manufactures spinal implants and instruments. The company provides products such as cervical implant systems, anterior cervical plate syste …
  • CytomX Therapeutics Inc (CTMX):製薬・医療:M&Aディール及び事業提携情報
    Summary CytomX Therapeutics Inc (CytomX) is a clinical-stage biopharmaceutical company which develops novel therapeutic antibodies and Probody therapeutics for the treatment of cancer. The company’s leading product candidates include CX-072, CX-2009, BMS-986249, CX-2029, CX-188, probody drug conjuga …
  • Deutsche Biotech Innovativ AG (VUA):製薬・医療:M&Aディール及び事業提携情報
    Summary Deutsche Biotech Innovativ AG (DBI), formerly Venetus Beteiligungen AG, is a biotechnology company that develops drug candidates on indications sepsis and cancer. The company’s products comprise Adrecizumab, DB1RA and AB2302. It diagnostic based drug development approach and offers identific …
  • Advantest Corporation (6857):企業の財務・戦略的SWOT分析
    Advantest Corporation (6857) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Takara Holdings Inc (2531):企業の財務・戦略的SWOT分析
    Takara Holdings Inc (2531) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Murree Brewery Co. Ltd.:企業の戦略・SWOT・財務分析
    Murree Brewery Co. Ltd. - Strategy, SWOT and Corporate Finance Report Summary Murree Brewery Co. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆